| FINVX | SVXCX | FINVX / SVXCX | |
| Total Expense Ratio | 0.01 | 2.01 | 0% |
| Annual Report Gross Expense Ratio | 0.01 | 2.28 | 0% |
| Fund Existence | 17 years | 11 years | - |
| Gain YTD | 7.115 | 22.389 | 32% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 25000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 17.8B | 305M | 5,836% |
| Annual Yield % from dividends | 4.06 | 0.90 | 450% |
| Returns for 1 year | 15.70 | 45.55 | 34% |
| Returns for 3 years | 74.64 | 92.71 | 81% |
| Returns for 5 years | 76.52 | N/A | - |
| Returns for 10 years | 134.54 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IONL | 53.50 | 3.05 | +6.05% |
| GraniteShares 2x Long IONQ Daily ETF | |||
| XLE | 57.96 | 0.66 | +1.15% |
| State Street®EngySelSectSPDR®ETF | |||
| DGIN | 34.31 | 0.19 | +0.57% |
| VanEck Digital India ETF | |||
| IDHQ | 41.64 | 0.07 | +0.17% |
| Invesco S&P International Dev Qual ETF | |||
| IDNA | 28.68 | -0.64 | -2.18% |
| iShares Genomics Immnlgy & Hlthcr ETF | |||